W. R. Berkley Corp
F:WR1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
W. R. Berkley Corp (WR1) under the Base Case is 62.88 EUR per share.
Compared with the current market price of 69.62 EUR, the stock appears
Overvalued by 10% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What W. R. Berkley Does
W. R. Berkley is a property and casualty insurance company. It sells commercial insurance coverages such as liability, workers’ compensation, property, and specialty policies to businesses, public entities, and certain individuals. The company also works through reinsurance and excess-and-surplus lines, which means it often writes harder-to-place or more specialized risks that many standard insurers avoid.
- Headquarters
- United States of America US
- Employees
- 8 804
- IPO date
- Oct 19, 1973
W. R. Berkley has a narrow economic moat
Specialized risk selection and claims handling help W. R. Berkley keep more of the premiums it collects. Its experienced insurance teams focus on particular industries and types of coverage, making their accumulated knowledge and operating processes difficult for newcomers to reproduce quickly.
Read the full moat analysisBalance Sheet
Recent Events
Latest Earnings Call
Berkley paired disciplined, selective underwriting with technology investment and a deliberate effort to exploit higher reinvestment yields amid evolving industry risks.
Open the earnings call- EPS
- $1.17
- Expected
- $1.14
- Surprise
- +2.6%
- Stock, next trading day
- −1.3%
W. R. Berkley insiders are buying more than usual
Past 12 months
Continue WR1 Research
Decided on W. R. Berkley? Get an email when WR1 reaches the price you’d buy at. Free with an account.
Other W. R. Berkley listings
What is the Intrinsic Value of one WR1 stock?
The intrinsic value for
W. R. Berkley Corp (WR1) under the Base Case is 62.88 EUR.
Is WR1 stock undervalued or overvalued?
Compared with the current market price of 69.62 EUR, the stock appears Overvalued by 10% .